INVESTIGATION OF MAIN INDICATORS FOR IMPLEMENTING A REGIONAL PREFERENTIAL DRUG PROVISION PROGRAM FOR THE POPULATION OF THE SAMARA REGION

Introduction. Preferential drug provision programs had a significant impact on the development of the pharmaceutical market. They are a measure of social support for citizens of all age groups, who live in different subjects of the Russian Federation. The public authorities of the subjects of the Russian Federation have authority to organize the provision of certain categories of citizens with essential medicines (regional preferential drug provision programs (RPDPP)). An analysis of the indicators of RPDPP implementation for a number of years makes it possible to comparatively investigate the cost structure of drugs and to scientifically substantiate approaches to rationally spending the budget funds, to creating the program budget, and to predicting the future demand for medicines. Objective: to investigate the features of drug use by beneficiaries of regional responsibility as part of RPDPP implementation in case of the Samara Region. Materials and methods. The investigation object was data on the nomenclature of drugs dispensed to the population of the Samara Region as part of RPDPP implementation in the period 2014 to 2018. The investigators analyzed the structure of a drug assortment according to the amount of financial costs; the price characteristics of groups in accordance with the anatomical therapeutic chemical (ATC) classification; and the scope of using the prescribed drugs in natural and monetary terms. The investigation used techniques for comparative, retrospective, logical, graphical, and content analyses and a method for data grouping according to the ATC classification. Results. By using the Samara Region as an example, the investigators carried out a comparative analysis of the changes in the main RPDPP implementation indicators (funding amounts for the implementation of the program; the actual average drug acquisition cost per applying beneficiary; the average cost of one prescription; the structure of costs depending on the category of beneficiaries, etc.), which had occurred in 2014-2018. It was established that more than 50% of the RPDPP budget allocated for the purchase of drugs is spent on drugs that affected the digestive tract and metabolism (mainly drugs for the treatment of diabetes mellitus), antineoplastic agents, and immunomodulators. Synthetic antidiabetic medications, as well as antiasthmatic drugs constituted a significant portion of the consumption structure in natural terms within the RPDPP. Conclusion. The analysis of changes in the main indicators of implementing RPDPP in the Samara Region over 2014-2018 identified the most costly categories of diseases for the RPDPP budget. The results of this analysis can be used as the basis for the development of methodological recommendations for the rational spending of budgetary funds, the creation of the program budget, and the prediction of future demand for drugs.

preferential drug provision, drug provision for regional beneficiaries, regional preferential drug provision program, assortment of drugs, ATC classification, costs of drugs by nosological entities